| Regulation of human Th9 differentiation by type I interferons and IL‐21 MT Wong, JJ Ye, MN Alonso, A Landrigan, RK Cheung, E Engleman, ... Immunology and cell biology 88 (6), 624-631, 2010 | 183 | 2010 |
| Engineering a ligand-dependent RNA transcriptional activator AR Buskirk, A Landrigan, DR Liu Chemistry & biology 11 (8), 1157-1163, 2004 | 124 | 2004 |
| IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice DL Thibault, AD Chu, KL Graham, I Balboni, LY Lee, C Kohlmoos, ... The Journal of clinical investigation 118 (4), 1417-1426, 2008 | 114 | 2008 |
| In vivo evolution of an RNA-based transcriptional activator AR Buskirk, PD Kehayova, A Landrigan, DR Liu Chemistry & biology 10 (6), 533-540, 2003 | 80 | 2003 |
| CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9-and MyD88-independent mechanism A Landrigan, MT Wong, PJ Utz The journal of immunology 187 (6), 3033-3043, 2011 | 56 | 2011 |
| Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81 Y Sagi, A Landrigan, R Levy, S Levy Proceedings of the National Academy of Sciences 109 (5), 1613-1618, 2012 | 41 | 2012 |
| Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion A Landrigan, G Yiu, K Agarwal, PJ Utz Leukemia & lymphoma 53 (1), 166-168, 2012 | 4 | 2012 |
| Therapeutic TLR agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion A Landrigan, G Yiu, K Agarwal, PJ Utz | | 2011 |
| Michael T Wongl, Jessica J. Yel, Michael N. Alonsoz, Angela Landriganl, Regina K. EE Cheungl, PJ Utz, MT Wong, JJ Ye, MN Alonso, A Landrigan, ... Regulation of Human T Helper Cell Differentiation, 121, 2011 | | 2011 |
| Toll-like Receptor Ligands Directly Activate Primary and Malignant T Lymphocytes A Landrigan Stanford University, 2009 | | 2009 |
| Su. 66. Toll-like Receptor Ligands Activate Mouse T Cell Lymphoma Lines and Modulate Activation of Primary T Cells A Landrigan, K Agarwal, P Utz Clinical Immunology, S145, 2008 | | 2008 |
